B-type Natruiretic Peptide Levels Stratify the Risk for Arrhythmia Among Implantable Cardioverter Defibrillator Patients

Ori Galante, Guy Amit, Doron Zahger, Abraham Wagshal, Reuben Ilia, Amos Katz
  • Clinical Cardiology, December 2008, Wiley
  • DOI: 10.1002/clc.20336

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1002/clc.20336

The following have contributed to this page: Dr ori galante

In partnership with: